腹膜后肿瘤的病理诊断与鉴别诊断
Retroperitoneal tumor: pathological diagnosis and differential diagnosis
王坚 . 腹膜后肿瘤的病理诊断与鉴别诊断[J]. 外科理论与实践, 2022 , 27(06) : 500 -505 . DOI: 10.16139/j.1007-9610.2022.06.04
| [1] | Messiou C, Moskovic E, Vanel D, et al. Primary retroperitoneal soft tissue sarcoma: imaging appearances, pitfalls and diagnostic algorithm[J]. Eur J Surg Oncol, 2017, 43(7):1191-1198. |
| [2] | Makise N, Yoshida A, Komiyama M, et al. Dedifferentia-ted liposarcoma with epithelioid/epithelial features[J]. Am J Surg Pathol, 2017, 41(11):1523-1531. |
| [3] | Agaimy A, Michal M, Hadravsky L, et al. Dedifferentia-ted liposarcoma composed predominantly of rhabdoid/epithelioid cells: a frequently misdiagnosed highly aggressive variant[J]. Hum Pathol, 2018, 77:20-27. |
| [4] | Saada-Bouzid E, Burel-Vandenbos F, Ranchère-Vince D, et al. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas[J]. Mod Pathol, 2015, 28(11):1404-1414. |
| [5] | Schaefer IM, Lundberg MZ, Demicco EG, et al. Relationships between highly recurrent tumor suppressor alte-rations in 489 leiomyosarcomas[J]. Cancer, 2021, 127(15):2666-2673. |
| [6] | Pérot G, Derré J, Coindre JM, et al. Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas[J]. Cancer Res, 2009, 69(6):2269-2278. |
| [7] | Colombo C, Miceli R, Lazar AJ, et al. CTNNB1 45F mutation is a molecular prognosticator of increased posto-perative primary desmoid tumor recurrence: an independent, multicenter validation study[J]. Cancer, 2013, 119(20):3696-3702. |
| [8] | Demicco EG, Wagner MJ, Maki RG, et al. Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model[J]. Mod Pathol, 2017, 30(10):1433-1442. |
| [9] | Tanaka T, Masumori N. Current approach to diagnosis and management of retroperitoneal fibrosis[J]. Int J Urol, 2020, 27(5):387-394. |
| [10] | 徐静, 张勇, 童汉兴, 等. 静脉内平滑肌瘤病的临床特征与外科治疗策略[J]. 中国临床医学, 2019, 26(3):369-373. |
| [11] | Fishbein L, Leshchiner I, Walter V, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma[J]. Cancer Cell, 2017, 31(2):181-193. |
| [12] | Muth A, Crona J, Gimm O, et al. Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma[J]. J Intern Med, 2019, 285(2):187-204. |
| [13] | Burgues O, Navarro S, Noguera R, et al. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma(Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry[J]. Virchows Arch, 2006, 449(4):410-420. |
| [14] | Hoshino Y, Yamada I, Shimano SI. Malignant lymphoma mimicking retroperitoneal fibrosis[J]. Intern Med, 2021, 60(20):3345-3346. |
/
| 〈 |
|
〉 |
